Buplant Trademark Details

This mark is alive with a status of Published for Opposition. The last case file activity for this mark occured 7 years ago on Tuesday, September 13, 2016, according to the United State Patent & Trademark Office
Word Mark Buplant
Status Alive 686 — Published for Opposition

Current Owner

Titan Pharmaceuticals, Inc. of South San Francisco, CA

View all trademarks for Titan Pharmaceuticals, Inc.
Other Trademarks for Titan Pharmaceuticals, Inc.
Serial Number 87009766
Status Date Tuesday, September 13, 2016
Filing Date Tuesday, September 13, 2016
Attorney Jennifer Lee Taylor

Correspondent

JENNIFER LEE TAYLOR
MORRISON & FOERSTER LLP
425 MARKET STREET
SAN FRANCISCO, CA 94105

Case File Statements

Goods & Services Pharmaceuticals, namely, implantable drug delivery system comprised primarily of a polymer-based subdermal matrix formulation for the sustained release of drugs in the treatment of opiate addiction and pain management; pharmaceuticals, namely, implantable drug delivery system comprised primarily of a polymer-based matrix formulation for the sustained release of drugs in the treatment of central nervous system disorders and other serious and life-threatening diseases

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 006, 018, 044, 046, 051, 052
Status 6 — Active
Status Date Tuesday, April 26, 2016
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.